Table 3 Sensitivity, specificity, and positive and negative predictive values according to different cutoff points in both, (a) derivation-internal validation and (b) external validation datasets.
Risk groups | No patients | Derivation cohort | No (%) deteriorated in complementary risk groups | |||
|---|---|---|---|---|---|---|
Sensitivity | Specificity | Positive predictive value | Negative predictive value | |||
Score > 0.04 | 1424 | 1 | 0.12 | 0.26 | 0.99 | 1 (0.69%) |
Score > 0.13 | 851 | 0.98 | 0.59 | 0.42 | 0.99 | 9 (1.26%) |
Score > 0.23 | 530 | 0.90 | 0.83 | 0.62 | 0.96 | 38 (3.66%) |
Score > 0.47 | 227 | 0.59 | 0.99 | 0.94 | 0.89 | 151 (11.26%) |
Score > 0.82 | 31 | 0.08 | 1 | 1 | 0.78 | 334 (21.73%) |
Risk groups | No patients | Validation cohort | No (%) deteriorated in complementary risk groups | |||
|---|---|---|---|---|---|---|
Sensitivity | Specificity | Positive predictive value | Negative predictive value | |||
Score > 0.04 | 862 | 0.99 | 0.12 | 0.22 | 0.99 | 1 (1.06%) |
Score > 0.13 | 525 | 0.86 | 0.53 | 0.31 | 0.94 | 26 (6.03%) |
Score > 0.23 | 313 | 0.65 | 0.75 | 0.40 | 0.90 | 67 (10.42%) |
Score > 0.47 | 98 | 0.33 | 0.95 | 0.64 | 0.85 | 128 (14.92%) |
Score > 0.82 | 13 | 0.06 | 1 | 0.92 | 0.81 | 179 (18.98%) |